Case File
efta-efta00762789DOJ Data Set 9OtherFrom: Jeffrey M Matusow
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00762789
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Jeffrey M Matusow
To: "Jeffrey Epstein ([email protected])" <[email protected]>
Cc: Paul S Barrett
, Justin X Gratz
Subject: Trade details
Date: Thu, 18 Mar 2010 18:03:51 +0000
Inline-Images: image001.gif
Jeffrey,
Here are the details of the trades you did yesterday:
Bought $5MM CIT 7% 5/1/17 bonds at $92.25 - 8.55% YTM
Bought $2.5MM Petroleos de Venezuela 4.9% 10/28/14 at $70.17 - YTM 13.891%
Receive fixed CLP 13BN (approx. $25MM) ly/ly at 4.15%, effective 3/21/11, maturity 3/21/12
Let us know if you have any questions.
Jeff
EFTA00762789
Not an official confirmation
JPMorgart Private Barth - t the marketing n.-eite for the private banking buanew conducted tie JPMorgart Chase & Co. ,
and its stilnlisales worldwide. IPMorpn Chase Bank, N. A and E. Morgan Trust Co., M. are members of the FDIC. I.P.
Morgan Securities Inc. (JPMSI) is a member of the New York Stock Bxchante and other national ard regional exchanges. JPMSI
t the trokr-dealer, member NASD, SIPC. In addition, IPMorpn Chase Sr. Co. may operate various other broker-dealers or
investment advisory entities.
The following is being provided for informational purposes only and/or in response u your request. Information contained in this
message and any accompanying documentation. including bat not limited t any research. market valuations. statement.
confirmations. cal: platens or estimates. is believed u be reliable, but we do not currant it completeness or accuracy. Opinions
and Quintets constitute our judgment and an subject to change without notice. Past performance is rut indicative of future result.
Tht material is not intended as en offer or soltitation for the purchase or role of any financial instrument. The broker-dealers
and/or their affiliates and employees may hold a position or act as market maker in the financial ilISIXOIR nit of any issuer discussed
herein or act as underwriter. placement agent. advisor or lender to such issuer. Valuations provided reflect price estimate: on the
date(s) specified. Please refer b year official statement/confirmation. We cannot guarantee that different prices mull not be
available elsewhere and suggest that several vuluaticou from other sources be obtained for the purpose of making nquired
calcolatons. Target prices and anticipated yields an bred upon researchmateriab and there can De no assurances that these prices
or yields can be realised. The cbbgations and the motrities mkt. offered, or recommethed, including mutual funds, are not
deposits °mime not obligations of, or mind
or guaranteed by, cow Loth or tlutft, nor are they tutted by the FDIC or
any govenmental Nency.
Please contact your .IPMagan Private Bank repremitative for further infamation or marring any tratl.-ction.
This inleormaticm is for the sole use of the penal to lekait it is addressed, and may be privihgol and confidential. Sty use,
distribution, or duplication by anyone other than the addressee is prohibited. If you receive this in error, please nail) the sender
immediately and return it by mail. 0 2035 JPMorgan Chase & Co.
Jeffrey M. Matusow
JPMorgan Private Bank I 40 West 57th Street, 33rd Floor, New York, NY 10019
Work: 212.622.7053 I Fax: 212.310.01081 Email:
IRS Circular 230 Disclosure:
JPMorgan Chase & Co. and its affiliates do not provide tax advice. Accordingly, any discussion of U.S. tax matters contained herein
(including any attachments) is not intended or written to be used, and cannot be used, in connection with the promotion, marketing
or recommendation by anyone unaffiliated with JPMorgan Chase & Co. of any of the matters addressed herein or for the purpose of
avoiding U.S. tax-related penalties.
EFTA00762790
Technical Artifacts (3)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.